Lululemon: The Five-Factor Read After Three Guidance Cuts

Lululemon stock has fallen approximately 80% from its December 2023 high of $511 to about $100 today. In a single afternoon on September 3, it dropped another 18% after the company cut its full-year guidance for the third time this year. The stock has since drifted to an 8-year low, and the price action screams a question: is this a bargain or a value trap?

The answer to that question depends on the difference between a cheap multiple and a working business. Let's look at what the numbers actually show.

The core product is collapsing

Lululemon built its premium valuation on one engine: women's leggings. That product was the category equivalent of a luxury good — high margin, high repeat purchase, little price competition. It's no longer.

In the second quarter of fiscal 2026, legging sales fell roughly 20%. Total revenue dropped 4% to $2.4 billion. Comparable sales — the measure that strips out new store openings and tells you whether existing customers are spending — declined 9%, or 10% on a constant-currency basis. The Americas, where Lululemon makes nearly two-thirds of its money, saw same-store sales plunge 12%. Internationally, the decline was narrower at 3%, but China contributed negative pressure after a botched marketing event at the Great Wall of China and a refusal to participate in local e-commerce promotions.

A 20% drop in your hero product isn't a soft quarter. It's evidence that the growth story the stock was built on has broken. Management is attempting to offset it with "away-from-body" styles — wide-leg pants and joggers — which are showing traction. But you can't replace a 20% collapse in your core with a trend that hasn't yet proven its scale.

Three guidance cuts tell a different story than one

Here's what matters more than the Q2 miss itself: the trajectory of the guidance cuts.

• March 2026: Full-year revenue guided at $11.35B to $11.50B, essentially flat year-over-year.
• June 2026: Trimmed to $11.00B to $11.15B, a small decline.
• September 2026: Slashed to $10.35B to $10.50B, now a 5% to 7% decline.

EPS guidance followed the same path, falling from the prior outlook of $10.95 to $11.15 per share down to $9.48 to $9.73. The third-quarter outlook projects another 10% to 11% revenue decline.

Three successive cuts in one year means the company does not yet know where the bottom is. It also means each guidance revision has been worse than the last — a deteriorating trend, not a one-off shock. The earnings estimate process, which is how the market continuously reprices expectations, is pointing down.

On a factor basis, earnings revisions are the strongest timing signal we have, and Lululemon's are D- — among the weakest in the sector. The direction has not stabilized.

The valuation is cheap. The factor stack says trap.

At a trailing P/E of 7.8x and a forward P/E of 8.1x, Lululemon is inexpensive. For comparison, Nike trades at 18.3x and Deckers Outdoor at 11.4x. Lululemon's EV/EBITDA of 3.8x would be remarkable for any consumer brand if the earnings behind it were stable.

But a low multiple is not an investment thesis — it's a starting point. The question is what the market is pricing in. Here's the five-factor read against apparel peers:

Factor	Grade	Evidence
Valuation	A+	7.8x P/E, 3.8x EV/EBITDA — cheapest in peer set
Growth	D-	Revenue down 4% YoY, comp sales down 9%, legging sales down ~20%
Profitability	C+	17.8% operating margin, 56.1% gross margin — compressed but still above most peers
Momentum	D-	Stock down ~80% from 52-week high; RSI at 31.5, deeply oversold
Earnings Revisions	D-	Three successive guidance cuts in 2026; EPS outlook falling each quarter

One A+ and four D-s. The valuation is cheap because the growth and profitability are under attack and the trajectory hasn't turned. That is the textbook definition of a value trap: cheap because the business is deteriorating faster than the multiple compresses.

Where the balance sheet creates a floor

Lululemon is not in financial distress. It holds $1.39 billion in cash, carries $3.69 billion in debt but with a 219% current ratio and a fortress liquidity position. Free cash flow over the trailing twelve months was $1.35 billion, growing 16% year-over-year and representing a 12.2% FCF margin. The company can fund itself through this downturn without dilution or forced asset sales.

That matters. It means this is a business problem, not a solvency problem. The stock won't be erased. But a strong balance sheet prevents catastrophe — it doesn't create upside.

What the new CEO inherits

Heidi O'Neill, a Nike veteran, takes the helm as CEO this week. Management has outlined an action plan centered on product creation, marketing investment, and disciplined cost management. Store expansion has been pulled back from 40 to about 35 net openings for the year; pop-up stores trimmed from 65 to around 40.

But O'Neill is inheriting a business where the guidance has been cut three times, the core product is collapsing, and brand sentiment has been damaged by a high-profile proxy fight with founder Chip Wilson and negative social media commentary. Turnaround plans at this stage are not optional — they're mandatory. And they require time to show results. The Q3 guidance of a 10% to 11% revenue decline tells you the back half is not that recovery quarter.

Morgan Stanley's view

Morgan Stanley maintains a Sell rating with a $93 price target, citing an "overextended" North American business and negative risk-reward. The $93 target is below where the stock trades now at $100, which means the firm sees further downside even after an 80% decline from the peak. That is not a contrarian signal — it's a recognition that the earnings trajectory hasn't stabilized.

The process answer

Lululemon is cheap. But cheap without growth, without positive revisions, and without momentum is not a buy — it's a watch. The factor stack here is unbalanced in a way that the valuation multiple alone doesn't fix.

The rally from a value trap requires at least one of these to happen first: comparable sales stabilize and stop declining, a guidance revision moves in the right direction, or the away-from-body product categories prove they can carry revenue without the legging engine. None of those have happened yet.

For your portfolio, Lululemon belongs on the watch list, not in the buy sleeve right now. The specific trigger that would move it forward is a quarter where comp sales stop falling — even if revenue still declines. That is the signal the deterioration is ending. Until then, the cheap multiple is real, but the business isn't finished falling.